SCYNEXIS INC
Federal contract awards won by SCYNEXIS INC (UEI H6PSJYEW3DT9), 2026–2026 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
1
award
0
expiring in 12 months
1
agency
Agencies buying from SCYNEXIS INC
What SCYNEXIS INC has provided
Awards
ADVANCE THE DEVELOPMENT OF SCY-247, A NOVEL ANTIFUNGAL CURRENTLY IN PHASE 1 CLINICAL TRIALS, FOR THE TREATMENT OF INVASIVE CANDIDIASIS AND PROPHYLAXIS OF INVASIVE FUNGAL DISEASE AS ORAL AND IC FORMULA
Department of Health and Human Services · $18,454,788 · Sep 15, 2026